Drug Profile
AQB 565
Alternative Names: AQB 565Latest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator Aequus BioPharma
- Class Antigouts; Peptide hormones; Recombinant fusion proteins
- Mechanism of Action Corticotropin receptor agonists; Melanin stimulants; Melanocyte modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gout